We provide evidence that (1) PTx2-3127 can reduce action potential discharges in an in vitro model of oxaliplatin-induced neuropathy, and (2) NaV1.7 contributes to human neuronal hyperexcitability in this model. Here, SCN9A is linked to neuropathy.